164 related articles for article (PubMed ID: 33125719)
1. Validated HPLC-UV method for simultaneous quantification of phosphatidylinositol 3-kinase inhibitors, copanlisib, duvelisib and idelalisib, in rat plasma: Application to a pharmacokinetic study in rats.
Siddesh A; Sriram D; Zakkula A; Kumar R; Dittakavi S; Zainuddin M; Trivedi RK; Mullangi R
Biomed Chromatogr; 2021 Apr; 35(4):e5015. PubMed ID: 33125719
[TBL] [Abstract][Full Text] [Related]
2. Validated liquid chromatography-tandem mass spectrometry method for simultaneous quantitation of bendamustine and copanlisib in mouse plasma: Application to a pharmacokinetic study in mice.
Tripathy HK; Manju SVN; Bestha RM; Kiran V; Dittakavi S; Mullangi R
Biomed Chromatogr; 2022 Aug; 36(8):e5387. PubMed ID: 35470912
[TBL] [Abstract][Full Text] [Related]
3. LC-ESI-MS/MS determination of copanlisib, a novel PI3K inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice.
Dittakavi S; Mullangi R
Biomed Chromatogr; 2019 Apr; 33(4):e4460. PubMed ID: 30536684
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry.
Veeraraghavan S; Thappali S; Viswanadha S; Nalla S; Chennupati S; Golla M; Vakkalanka S; Rangasamy M
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 949-950():63-9. PubMed ID: 24463402
[TBL] [Abstract][Full Text] [Related]
5. Validated HPLC method for quantification of copanlisib in mice plasma: application to a pharmacokinetic study.
Zakkula A; Kurakula PK; Dittakavi S; Daram P; Bestha RM; Zainuddin M; Trivedi RK; Mullangi R
ADMET DMPK; 2020; 8(1):113-121. PubMed ID: 35299776
[TBL] [Abstract][Full Text] [Related]
6. A Highly Sensitive Nonextraction-Assisted HPLC Method with Fluorescence Detection for Quantification of Duvelisib in Plasma Samples and its Application to Pharmacokinetic Study in Rats.
Sayed AY; Khalil NY; Almomen A; Alzoman NZ; Almehizia AA; Darwish IA
Drug Des Devel Ther; 2021; 15():2667-2677. PubMed ID: 34188446
[TBL] [Abstract][Full Text] [Related]
7. Validated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mouse plasma: Application to a pharmacokinetic study.
Zakkula A; Dittakavi S; Maniyar MM; Syed N; Sulochana SP; Zainuddin M; Mullangi R
Biomed Chromatogr; 2019 Nov; 33(11):e4658. PubMed ID: 31325170
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel and quick UPLC-MS/MS method for the pharmacokinetic analysis of duvelisib in beagle dogs.
Shao Y; Xie S; Zhu H; Du X; Xu RA
J Pharm Biomed Anal; 2020 Aug; 187():113355. PubMed ID: 32442869
[TBL] [Abstract][Full Text] [Related]
9. Validated HPLC-UV method for quantification of paxalisib, a pan PI3K and mTOR inhibitor in mouse plasma: Application to a pharmacokinetic study in mice.
Zakkula A; Tripathy HK; Bestha RM; Vinod AB; Kiran V; Dittakavi S; Mullangi R
Biomed Chromatogr; 2023 Apr; 37(4):e5587. PubMed ID: 36680551
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a RP-HPLC method for the quantitation of tofacitinib in rat plasma and its application to a pharmacokinetic study.
S VK; Dhiman V; Giri KK; Sharma K; Zainuddin M; Mullangi R
Biomed Chromatogr; 2015 Sep; 29(9):1325-9. PubMed ID: 25622797
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of idelalisib and its metabolite GS-563117 in dog plasma by LC-MS/MS: Application to a pharmacokinetic study.
Wang C; Jia F; Zhang Y
Biomed Chromatogr; 2019 May; 33(5):e4511. PubMed ID: 30773664
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Göckeritz E; Kerwien S; Baumann M; Wigger M; Vondey V; Neumann L; Landwehr T; Wendtner CM; Klein C; Liu N; Hallek M; Frenzel LP; Krause G
Int J Cancer; 2015 Nov; 137(9):2234-42. PubMed ID: 25912635
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of an HPLC Method for Quantification of Filgotinib, a Novel JAK-1 Inhibitor in Mice Plasma: Application to a Pharmacokinetic Study.
Zakkula A; Pulipati S; Dittakavi S; Bestha RM; Zainuddin M; Trivedi RK; Mullangi R
Drug Res (Stuttg); 2020 May; 70(5):233-238. PubMed ID: 32289835
[TBL] [Abstract][Full Text] [Related]
14. A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib.
Proudman D; Nellesen D; Gupta D; Adib D; Yang J; Mamlouk K
Adv Ther; 2022 Apr; 39(4):1678-1696. PubMed ID: 35157216
[TBL] [Abstract][Full Text] [Related]
15. Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib.
Krause G; Hassenrück F; Hallek M
Drug Des Devel Ther; 2018; 12():2577-2590. PubMed ID: 30174412
[TBL] [Abstract][Full Text] [Related]
16. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
Sengottuvelan S; Uppal R; Vuppu S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
[TBL] [Abstract][Full Text] [Related]
17. Validated LC-MS/MS method for the determination of copanlisib in mouse dried blood spots.
Tripathy HK; Kiran V; Zakkula A; A B V; Bestha RM; Dittakavi S; Mullangi R
Biomed Chromatogr; 2023 Feb; 37(2):e5548. PubMed ID: 36385469
[TBL] [Abstract][Full Text] [Related]
18. DBS Assay with LC-MS/MS for the Determination of Idelalisib, A Selective PI3K-δ Inhibitor in Mice Blood and Its Application to a Pharmacokinetic Study.
Tripathy HK; Manju NSV; Dittakavi S; Zakkula A; Mullangi R
Drug Res (Stuttg); 2021 Jan; 71(1):36-42. PubMed ID: 32992346
[TBL] [Abstract][Full Text] [Related]
19. Validated RP-HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats.
Kumar SV; Rudresha G; Gurav S; Zainuddin M; Dewang P; Kethiri RR; Rajagopal S; Mullangi R
Biomed Chromatogr; 2013 Feb; 27(2):203-7. PubMed ID: 22763809
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.
Kumar A; S VK; Gurav S; Zainuddin M; Dewang P; Kethiri RR; Rajagopal S; Mullangi R
Biomed Chromatogr; 2013 Dec; 27(12):1590-4. PubMed ID: 23788266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
